CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Botucatu. Faculdade de Medicina (FMB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Medicina from Universidade Federal de Goiás (1991) and doctorate at Clinical Medicine from Universidade Estadual Paulista Júlio de Mesquita Filho (2004). Has experience in Medicine, focusing on Hematology, acting on the following subjects: biologia molecular, cancerologia, hematologia, human identification and educação médica. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Patients with hematological malignancy have compromised immunity due to the malignancy of the disease and/or treatment, leading to a high risk for severe COVID-19. However, most of the scientific studies available gather patients with hematological malignancies and solid tumors in a single group, making no distinction as to the different types of hematological tumors and their treatments.…
Chronic Myeloid Leukemia (CML) is a malignant clonal hematopoietic stem cell disease. The discovery of the Philadelphia chromosome and subsequent identification of the gene bcr-abl have led to understanding the biology of the disease and the development of target-specific drugs, as well as molecular methods for monitoring the disease. The current focus of research in the CML is facing the…
Introduction: Patients with hematological malignancy have compromised immunity due to the malignancy of the disease and/or treatment, leading to a high risk for severe COVID-19. However, most of the scientific studies available gather patients with hematological malignancies and solid tumors in a single group, making no distinction as to the different types of hematological tumors and the…
Chronic Myeloid Leukemia (CML) is a malignant clonal hematopoietic stem cell disease. The discovery of the Philadelphia chromosome and subsequent identification of the gene bcr-abl have led to understanding the biology of the disease and the development of target-specific drugs, as well as molecular methods for monitoring the disease. The current focus of research in the CML is facing the…
| 1 / 1 | Ongoing grants |
| 1 / 1 | Completed research grants |
| 3 / 2 | Completed scholarships in Brazil |
| 5 / 4 | All research grants and scholarships |
| Associated processes | |